What question did this study set out to answer?

To identify the metabolic pathway that generates arachidonic acid precursors for proinflammatory prostaglandin production in the brain and test its therapeutic relevance.

October 21, 2011Science

Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation

View Full Paper

Ask AI

Bookmark

Authors

DNDaniel K. Nomura BMBrad E. Morrison JBJacqueline L. Blankman

Discussion

Member takes

Overview

Preclinical study reveals that MAGL hydrolyzes endocannabinoids to generate neuroinflammatory prostaglandins in mouse models, suggesting a safer therapeutic target for neurodegenerative disease.

Key Points

To identify the metabolic pathway that generates arachidonic acid precursors for proinflammatory prostaglandin production in the brain and test its therapeutic relevance.
Evaluated prostaglandin synthesis pathways in the brain and gut of mice with disrupted monoacylglycerol lipase (MAGL).
Assessed neuroprotective outcomes using a parkinsonian mouse model.
Examined gastrointestinal bleeding side effects following MAGL disruption compared with conventional cyclooxygenase (COX) inhibition.
MAGL hydrolyzes the endocannabinoid 2-arachidonoylglycerol to serve as the primary source of arachidonic acid for neuroinflammatory prostaglandin synthesis in the brain.
Disruption of MAGL confers significant neuroprotection in a mouse model of Parkinson's disease.
MAGL-disrupted animals avoid gastrointestinal hemorrhaging because gut prostaglandins are maintained independently by cytosolic phospholipase A(2).

Cite This Study

Nomura et al. (2011) studied this question.

synapsesocial.com/papers/69d87bf752654bb436d193bc https://doi.org/10.1126/science.1209200

View Full Paper

Ask AI

Bookmark

October 21, 2011Science

Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation

View Full Paper

Ask AI

Bookmark

Authors

DNDaniel K. Nomura BMBrad E. Morrison JBJacqueline L. Blankman

Discussion

Member takes

Overview

Preclinical study reveals that MAGL hydrolyzes endocannabinoids to generate neuroinflammatory prostaglandins in mouse models, suggesting a safer therapeutic target for neurodegenerative disease.

Key Points

To identify the metabolic pathway that generates arachidonic acid precursors for proinflammatory prostaglandin production in the brain and test its therapeutic relevance.
Evaluated prostaglandin synthesis pathways in the brain and gut of mice with disrupted monoacylglycerol lipase (MAGL).
Assessed neuroprotective outcomes using a parkinsonian mouse model.
Examined gastrointestinal bleeding side effects following MAGL disruption compared with conventional cyclooxygenase (COX) inhibition.
MAGL hydrolyzes the endocannabinoid 2-arachidonoylglycerol to serve as the primary source of arachidonic acid for neuroinflammatory prostaglandin synthesis in the brain.
Disruption of MAGL confers significant neuroprotection in a mouse model of Parkinson's disease.
MAGL-disrupted animals avoid gastrointestinal hemorrhaging because gut prostaglandins are maintained independently by cytosolic phospholipase A(2).

Cite This Study

Nomura et al. (2011) studied this question.

synapsesocial.com/papers/69d87bf752654bb436d193bc https://doi.org/10.1126/science.1209200

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark